ResearcherFirst Hospital of Lanzhou UniversityActive in the last 2 years
Wenbo Meng
Matched on ORCID iD 0000-0002-9355-0225; OpenAlex author ID A5010495985. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- The Role of Serum Uric Acids in Protecting Postoperative Survival in Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-9008446/v1↗
- Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study. Last author DOI 10.3748/wjg.v26.i44.7061↗
- Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Co-author DOI 10.1002/jcp.26816↗
- Overexpression of p16ink4a regulates the Wnt/β‑catenin signaling pathway in pancreatic cancer cells. Co-author DOI 10.3892/mmr.2017.8139↗
- 5-Azacytidine suppresses the proliferation of pancreatic cancer cells by inhibiting the Wnt/β-catenin signaling pathway. Co-author DOI 10.4238/2014.july.4.22↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhengping An · 1 shared paper, 2026 · strength 0.32
- Wence Zhou · 2 shared papers, 2018 · strength 0.17
- Xun Li · 1 shared paper, 2020 · strength 0.09
- Jinqiu Yuan · 1 shared paper, 2020 · strength 0.09
- Chongfei Huang · 1 shared paper, 2020 · strength 0.09
- Hui Zhang · 1 shared paper, 2018 · strength 0.09
- Lei Zhang · 1 shared paper, 2018 · strength 0.09
- Shaozhen Rui · 1 shared paper, 2018 · strength 0.08
- Xiao‐Da Jin · 1 shared paper, 2018 · strength 0.08
- Hui Zhang · 1 shared paper, 2018 · strength 0.08
- H. Zhang · 1 shared paper, 2014 · strength 0.04
- Yanan Li · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.